Pharmafile Logo

Research Partnership ranks 13th in the top 20 fastest-growing agencies in the UK

February 4, 2019 | Pharma, healthcare, market research 

The UK’s best performing market research agencies were revealed earlier this month with the publication of Research Live’s Industry Report for 2019, which includes the latest Market Research Society (MRS) League Tables. Based on 2017 financial data that was compiled and analysed in November 2018, the MRS league tables identify and rank the best-performing research agencies and businesses according to their UK-based turnover and by their year-on-year growth.

With a growth rate of 21.87%, Research Partnership has been ranked 13th in the top 20 fastest-growing individual agencies. In addition, with over £27.5 million in sales, the company ranked 25th in the top 50 consolidated businesses, which draws agencies together under ownership groups, and 27th in the top 100 individual agencies, both of which are ranked by annual turnover.

Founding Director Mark Jeffery was interviewed for the report’s ‘Perspective from the Fastest Growers’ to find out how Research Partnership is achieving growth in an uncertain climate. Mark commented, “We are delighted to see Research Partnership placed so well in the league tables again this year. Our senior level and business development teams work hard to secure new clients, and our research teams ensure that we receive repeat business by delivering the very best service. We celebrated our 20th anniversary last year and have enjoyed consistent growth every year since we started. As a result we are now the largest independent healthcare market research agency in the world, working with all the major global pharma organisations.”

In the past year Research Partnership’s has also expanded into the medical technology space, built up the company’s market access capabilities, opened three new offices across the US and Europe, and grown the workforce by 15%.

Read the full report here »

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: North Asia

An overview of the five most-commonly researched, largest pharma markets in North Asia.

Infographic: PsO market snapshot

An overview of the PsO biologic and systemic patientOur PsO market snapshot offers an introduction to the real world patient data collected by our Therapy Watch PsO study. The snapshot...

Infographic: Prostate Cancer Market Snapshot

An overview of the prostate cancer patientDownload our Therapy Watch PCa market snapshot which provides you with an overview of the prostate cancer patient and the therapy regimens followed by...

Infographic: LATAM

Latin AmericaThe LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region. With...

Infographic: RA market snapshot

An overview of the RA biologic patientOur RA market snapshot will provide you with an introduction to the treatment pathways followed by RA patients treated with biologic agents. Our analyses...

Infographic: CEE

The Central and Eastern Europe region is home to over 145 million people and is a key global growth region. With pharmaceutical sales set to exceed $27bn in 2014, it...

Infographic: ASEAN-6

Home to over half a billion people, the ASEAN region constitutes the eighth largest economy in the world. With pharmaceutical sales projected to exceed $20 billion in 2014, it’s an...

Infographic: HCV – The Roadblocks to Effective Treatment

Referencing data from our Living with HCV survey undertaken with patients in the US and China, this infographic explores the roadblocks encountered on the path to effective and compliant treatment.Hepatitis C is...

Turkey: Identifying the Growth Drivers

Published in eye for pharma 3 April by Marc Yates

Article: The Patient Abroad

Published in Medical Marketing & Media March 2015